Nucleus RadioPharma, a contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has appointed Dr. Stephen M. Hahn as Chief Executive Officer (CEO). “Steve’s experience as both a physician treating patients and as a leader at the FDA brings an unparalleled perspective to Nucleus as the company works to build the infrastructure needed to accelerate the widespread availability of radiopharmaceuticals,” said Justin Butler, partner at Eclipse and Nucleus boa...